CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF MURAMYL DIPEPTIDE IN THE TREATMENT OF ATOPIC DISEASES
Increased incidence of allergic diseases worldwide reflects some mangles of the existing pharmacotherapy concept which ignores some etiopathogenetic aspects of clinical atopy. Meanwhile, understanding cellular and molecular mechanisms of allergy may create prerequisites for development of new therap...
Guardado en:
Autores principales: | N. V. Kolesnikova, I. G. Kozlov, S. V. Guryanova, E. A. Kokov, T. M. Andronova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57fb33f05cbf4155ba78d2433241ed42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative prevalence of atopic sensitization in the border areas between Russia and Finland
por: O. A. Markelova, et al.
Publicado: (2020) -
MATURATION OF MACROPHAGES UNDER THE INFLUENCE OF MURAMYL PEPTIDES
por: A. Il’inskaya, et al.
Publicado: (2014) -
APPLICATION OF INHIBITOR ANALYSIS FOR STUDYING MECHANISMS AND ACTIONS OF POLYMURAMYL, A MURAMYL PEPTIDE-BASED IMMUNE MODULATOR
por: M. V. Pashenkov, et al.
Publicado: (2014) -
A combination of three muramyl peptides derived from gramnegative bacteria in immunotherapy of chronic pyodermia
por: O. V. Kalyuzhin, et al.
Publicado: (2020) -
Atopy in Kashmir-validation from a case control study with respect to IgE and Interleukin genes
por: Taha Ashraf Qurashi, et al.
Publicado: (2021)